C Athena Aktipis

Summary

Affiliation: Arizona State University
Country: USA

Publications

  1. pmc Evolutionary foundations for cancer biology
    C Athena Aktipis
    Center for Evolution and Cancer, University of California San Francisco, CA, USA Department of Psychology, Arizona State University Tempe, AZ, USA
    Evol Appl 6:144-59. 2013
  2. pmc Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research
    C Athena Aktipis
    Department of Psychology, Arizona State University, Tempe, Arizona, United States of America
    PLoS ONE 6:e26100. 2011
  3. pmc Life history trade-offs in cancer evolution
    C Athena Aktipis
    1 Center for Evolution and Cancer and the Department of Surgery, University of California San Francisco, 2340 Sutter Street, Box 1351, San Francisco, California 94143 1351, USA 2 Department of Psychology, Arizona State University, PO Box 871104, Tempe, Arizona 85287 1104, USA
    Nat Rev Cancer 13:883-92. 2013

Collaborators

Detail Information

Publications3

  1. pmc Evolutionary foundations for cancer biology
    C Athena Aktipis
    Center for Evolution and Cancer, University of California San Francisco, CA, USA Department of Psychology, Arizona State University Tempe, AZ, USA
    Evol Appl 6:144-59. 2013
    ....
  2. pmc Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research
    C Athena Aktipis
    Department of Psychology, Arizona State University, Tempe, Arizona, United States of America
    PLoS ONE 6:e26100. 2011
    ..This represents an unrealized opportunity for advances in research on therapeutic resistance...
  3. pmc Life history trade-offs in cancer evolution
    C Athena Aktipis
    1 Center for Evolution and Cancer and the Department of Surgery, University of California San Francisco, 2340 Sutter Street, Box 1351, San Francisco, California 94143 1351, USA 2 Department of Psychology, Arizona State University, PO Box 871104, Tempe, Arizona 85287 1104, USA
    Nat Rev Cancer 13:883-92. 2013
    ..Life history theory suggests that different therapy dosing schedules might select for fast or slow life history cell phenotypes, with important clinical consequences. ..